This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gorczyca DP, Sinha S, Ahn CY, et al. Silicone breast implants in vivo: MR imaging. Radiology 1992;185:407–410.
Gorczyca DP, DeBruhl ND, Ahn CY, et al. Silicone breast implant ruptures in an animal model: comparison of mammography, MR imaging, US and CT. Radiology 1994;190:227–232.
Berg WA, Caskey CI, Hamper UM, et al. Single-and double-lumen silicone breast implant integrity: prospective evaluation of MR and US criteria. Radiology 1995;197:45–52.
Berg WA, Nguyen TK, Middleton MS, et al. MR imaging of extracapsular silicone from breast implants: diagnostic pitfalls. AJR Am J Roentgenol. 2002;178:465–472.
Hrung JM, Langlotz CP, Orel SG, et al. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions. Radiology 1999;213:39–49.
Lee CH, Smith RC, Levine JA, et al. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol. 1999;173:1323–1329.
Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;196:387–395.
Brink U, Rischer U, Korabiowska M, et al. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR Am J Roentgenol. 1997;168:1331–1334.
Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994;190:485–493.
Matsubayashi R, Matsuo Y, Edakuni G, et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841–848.
Fobben ES, Rubin C, Kalisher L, et al. Breast MR imaging with commercially available techniques: radiology-pathologic correlation. Radiology 1995;196:143–152.
Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493–501.
Wedegaertner U, Bick U, Woertler K, et al. Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria. Eur Radiol. 2001;11:1645–1650.
Westerhof JP, Fischer U, Moritz JD, Oestmann JW. MR imaging of mammographically detected clustered microcalcifications: is there any value? Radiology 1998;207:675–681.
Gilles R, Guinebretiere J, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994;191:625–631.
Liberman L, Morris EA, Lee MJY, et al. Breast lesions detected by MR imaging: features and positive predictive value. AJR Am J Roentgenol. 2002;179:171–178.
Slanetz PJ, Edmister WB, Yeh ED, et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J. 2002;8:145–148.
Brown J, Smith RC, Lee CH. Incidental enhancing lesions found on MR imaging of the breast. AJR Am J Roentgenol. 2001;176:1249–1254.
Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology 1997;202:833–841.
Siegmann KC, Muller-Schimpfle M, Schick F, et al. MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol. 2002;178:1403–1409.
LaTrenta LR, Menell JH, Morris EA, et al. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 2003;227:856–861.
Panizza P, De Gaspari A, Vanzulli A, et al. Accuracy of post-MR imaging second-look-sonography in previously undetected breast lesions [abstract]. Radiology 1997;205:489.
Dhamanaskar KP, Muradall D, Kulkarni SR, et al. MRI directed ultrasound: a cost effective method for diagnosis and intervention in breast imaging [abstract]. Radiology 2002;225:653.
Hlawatsch A, Teifke A, Schmidt M, Thelen M. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol. 2002;179:1493–1501.
Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743–737.
Weinstein SP, Orel SG, Heller R, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol. 2001;176:399–406.
Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol. 2002;178:1227–1232.
Frei KA, Kinkel K, Bonel HM, et al. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol. 2001;175:1577–1584.
Gilles R, Guinebretiere J, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993;188:473–478.
Dao TH, Rahmouni A, Campana F, et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751–755.
Dershaw DD, McCormick B, Cox L, Osborne MP. Differentiation of benign and malignant local tumor recurrence after lumpectomy. AJR Am J Roentgenol. 1990;155:35–38.
Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13–30.
Gilles R, Guinebretiere JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633–638.
Partridge SC, Gibbs JE, Lu Y, et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002;179:1193–1199.
Junkermann H, von Fournier D. Imaging procedures for assessment of the response of mamary carcinoma to preoperative chemotherapy. Der Radiologe 1997;37:726–732.
Rieber A, Brambs HJ, Gabelmann A, et al. Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol. 2002;12:1711–1719.
Wasser K, Sinn HP, Fink C, et al. Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol. 2003;13:1213–1223.
Orel SG, Dougherty CS, Reynolds C, et al. MR imaging in patients with nipple discharge: initial experience. Radiology 2000;216:248–254.
Yoshimoto M, Kasumi F, Iwase T, et al. Magnetic resonance galactrography for a patient with nipple discharge. Breast Cancer Res Treat. 1997;42:87–90.
Ralleigh G, Walker AE, Hall-Craggs MA, et al. MR imaging of the skin and nipple of the breast: differentiation between tumour recurrence and post-treatment change. Eur Radiol. 2001;11:1651–1658.
Douek M, Hall-Craggs MA. Can the use of preoperative MR imaging reduce local recurrence rates in patients with retroareolar breast cancer who undergo breast-conservation surgery? [letter]. Radiology 1999;210:880–881.
Buadu AA, Buadu LD, Murakami J, et al. Enhancement of the nipple-areolar-complex on contrast-enhanced MR imaging of the breast. Breast Cancer 1998;5:285–289.
Kothari AD, Beechey-Newman N, Hamed H, et al. Paget disease of the nipple, a multifocal manifestation of higher-risk disease. Cancer 2002;95:1–7.
Morris EA, Schwartz LH, Dershaw DD, et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437–440.
Rosen PP. Unusual clinical presentations of carcinoma. In: Rosen PP, ed. Rosen’s Breast Pathology. Philadelphia: Lippincott-Raven; 1997:567–595.
Olson JA Jr, Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411–415.
Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999;212:543–549.
Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol. 2001;19:3524–3531.
Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst. 2001;93:1095–1102.
Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol. 2003;181:619–626.
Liberman L. Breast cancer screening with MRI—what are the data for patients at high risk? (editorial) N Engl J Med 2004;351:497–500.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Dershaw, D.D. (2005). Magnetic Resonance Imaging as a Clinical Tool. In: Breast MRI. Springer, New York, NY. https://doi.org/10.1007/0-387-27595-9_16
Download citation
DOI: https://doi.org/10.1007/0-387-27595-9_16
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-21997-4
Online ISBN: 978-0-387-27595-6
eBook Packages: MedicineMedicine (R0)